Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
23andMe
MedTech
Anne Wojcicki steps down to bid on 23andMe’s bankruptcy auction
The genetic testing company has filed for Chapter 11 bankruptcy and will pursue a court-managed sale.
Conor Hale
Mar 24, 2025 10:43am
23andMe shutters cancer drug research, lays off 40% of staff
Nov 11, 2024 9:07pm
23andMine: Anne Wojcicki aims to take genetics company private
Apr 18, 2024 9:16am
23andMe lands new label for cholesterol drug response report
Oct 27, 2022 11:12am
23andMe snags 3rd FDA nod for genetic cancer risk test
Jan 10, 2022 11:58am
23andMe to go public in $3.5B deal backed by Virgin
Feb 4, 2021 11:25am